Symptomtext
Fatigue; Chills; Body Aches; Fever; Injection site pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 29Oct2021 08:30 (Lot number: EN0217) at the age of 32 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2 at 15:30 PM, Batch/Lot No: ER5734, Intramuscular in Arm Left), administration date: 07Apr2021, when the patient was 31 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1 at 16:30 PM, Batch/Lot No: EN6207, Intramuscular in Arm Left), administration date: 17Mar2021, when the patient was 31 years old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 29Oct2021 20:00, outcome "recovered" (Oct2021), described as "Fatigue"; CHILLS (non-serious) with onset 29Oct2021 20:00, outcome "recovered" (Oct2021), described as "Chills"; PAIN (non-serious) with onset 29Oct2021 20:00, outcome "recovered" (Oct2021), described as "Body Aches"; PYREXIA (non-serious) with onset 29Oct2021 20:00, outcome "recovered" (Oct2021), described as "Fever"; VACCINATION SITE PAIN (non-serious) with onset 29Oct2021 20:00, outcome "recovered" (Oct2021), described as "Injection site pain". Therapeutic measures were not taken as a result of fatigue, chills, pain, pyrexia, vaccination site pain. Additional information: No other vaccine in four weeks. No covid prior vaccination. Not tested for covid post vaccination. No known allergies. Concomitant drugs reported as None, Relevant test were None. Follow-up attempts are completed. No further information is expected.